Events

Wednesday, February 5 @ 8:00 AM PT / 11:00 AM ET

Eric Johansen, PhD - R&D Scientist, CDI Labs

In this GEN webinar, our speaker, Eric Johansen, PhD, will demonstrate the utility of virion-displayed membrane proteins for screening antibody biologics. He will present the VirD membrane protein array technology, which displays membrane proteins in the membrane envelope of herpes simplex virus-1 (HSV-1) virions. The technology is designed for high-throughput biochemical analysis of membrane proteins. Membrane protein expression occurs during virus replication, ensuring that the integrated proteins undergo endogenous folding and post-translational modifications in their native and active conformations. He will also share the results of testing various commercial and clinical antibodies.

REGISTER HERE

SITC 2024 provides a multidisciplinary educational and interactive environment focused on improving outcomes for cancer patients by incorporating strategies based on basic and applied cancer immunotherapy. The Annual Meeting consists of cutting-edge research presentations by experts in the field, oral and poster abstract presentations and ample opportunity for structured and informal discussions, including important networking opportunities. SITC 2024 also includes updates on major national and international initiatives from academia, government and industry, as well as important society projects.

Join Us for

Happy Hour!

Friday, November 8 from 4:30 - 7:30 pm @ PITCH 25 (directions below)

Get ready for a fun Friday night on November 8th from 4:30 to 7:30 PM at the PITCH 25 Beer Garden, just a stone's throw away from the convention center. You are cordially invited! Come and join the CDI Labs team for an evening filled with refreshing drinks and food during SITC 2024. This is your opportunity to socialize with colleagues and friends, engage in discussions about your projects, or simply unwind with a delightful gathering of merry scientists.

> Directions to PITCH 25

2120 Walker St
Houston, TX 77003

Please RSVP for this event using the form on this page.  

The NIH Research Festival is a yearly multi-day celebration of scientific discoveries and advances happening throughout NIH labs and clinics. This year’s festival will feature scientific lectures and posters, workshops, information tables, technical vendor booths, special food trucks and local entertainment. All are welcome; no registration is required for attendees.

JOIN US

CDI Labs Workshop

Wednesday, September 25 @ 1:15 - 2:15 pm (Room 1)

TITLE:

"Tools for Autoantibody Discovery"

While autoantibodies have traditionally been suspected in disease areas like multiple sclerosis and rheumatoid arthritis, there is a growing body of evidence that autoantibodies are involved in a diverse range of disease areas such as cancer (immunotherapy outcomes and putative therapeutics), obesity, psychiatric disorders, neurodegenerative diseases, and may others. Oftentimes these autoantibodies are formed in response to viral infections. It is increasingly clear that each individual’s autoantibody repertoire is incredibly unique, complex, and yet accessible and understandable via CDI Labs’ HuProt™ Microarray and VirScan®, HuScan®, MouseScan™ PhIP-Seq (phage immunoprecipitation sequencing) assays.

Mike Morrow - Business Development, CDI Labs

Please register for this workshop using the form on the right-side of this page.  

Keynote Speaker

Andrew McKeon M.B., B.Ch., M.D. - Mayo Clinic

"Autoantibodies: Pathogenesis, Diagnosis, and Prognosis"

Vision 2035: An Entrepreneurial Future for Latin America + the Caribbean

Thousands of founders, investors, entrepreneurship ecosystem builders, policymakers, researchers and more are coming together to explore an ambitious roadmap for a more vibrant and thriving economy by 2035. This vision will build on the optimism of those who dream, ideate, iterate, take risks and execute – entrepreneurs – to drive action on new ideas at the intersection of the most diverse economies within the region. Join us at this year's defining event for the entrepreneurship ecosystem across Latin America and the Caribbean.

FOCIS is THE meeting in translational immunology that will give you a competitive edge in your career. Stay ahead of the curve with leading clinicians and researchers delivering the latest breakthroughs across immune-mediated diseases. Focusing on molecular pathways and their implications in human disease provides the unique opportunity for innovative thinking and applying ideas from the pathologies of other diseases to uncover novel solutions to challenges in the diseases you study.

JOIN US

Poster Presentation

Tuesday, June 18 @ 6:00 - 7:30 pm (Salon 9, Lower B2 Level)

Poster: Tu138

"High-throughput Serology of Identical Twin Ageing Demonstrates Stability and Genetic Independence of Antibody Memory"

Tyler Hulett, PhD - CSO, CDI Labs

Recent advances in high-throughput synthetic biology tools enable massively multiplexed serologic profiling of antigen-specific antibody repertoires by proteome microarray and phage-display immunoprecipitation sequencing (PhIP-Seq). However, little remains known about the impact of individual genetics on these global profiles or repertoire stability across time.

Welcome to hubXchange’s Immuno-Oncology Xchange Boston 2024, bringing together executives from pharma and biotech to address and find solutions to the key issues faced in developing immuno-oncology therapies, through a series of roundtable discussions. Discussion topics will cover Immune Biomarkers, Translational Research, Clinical Development, and Tumor Microenvironment. Take advantage of this unique highly interactive meeting format designed for maximum engagement and collaboration with your peers.

Wednesday, May 15 @ 8:00 am / 11:00 am

"Discovering Novel Immune Biomarkers and Druggable Targets with Seromics"

Tyler Hulett, PhD - CSO, CDI Labs

Seromics, the study of the total secreted antibody repertoire in serum and other bodily fluids,is traditional serology reborn in high-throughput. While the field is still emerging, it is already clear that each individual’s serome is incredibly unique, impossibly complex, and yet surprisingly accessible via proteome microarrays (HuProt™), phage-display immunoprecipitation sequencing (PhIP-Seq, HuScan®, VirScan™), and other new synthetic biology platforms. Seromics experiments have revealed a viral-induced autoimmune cause of multiple sclerosis, pre-treatment autoantibodies associated with checkpoint blockade immunotherapy outcomes, and the demonstration that autoantibodies can mimic inborn errors of immunity – genetic-knockout-like phenotypes only discoverable via antibody profiling. This talk will introduce what might be accomplished via broader application of seromics platforms today and the development needed to interrogate the serome more completely in the future.

REGISTER HERE

The Leading Annual All-Immunology Event Worldwide - #AAI2024

JOIN US

Theater Workshop

Sunday, May 5 @ 9:30 am (Level 3, Hall F1 - Exhibitor Workshop #2)
(Light breakfast will be served)

"Seromics: A New Frontier of Immune Biomarkers and Druggable Target Discovery"

Tyler Hulett, PhD - CSO, CDI Labs

It is already clear that each individual’s serome is incredibly unique, complex, and yet accessible via proteome microarrays (HuProt), phage-display immunoprecipitation sequencing (PhIP-Seq, HuScan, VirScan), and other new synthetic biology platforms. Seromics experiments have revealed a viral-induced autoimmune cause of multiple sclerosis, pre-treatment autoantibodies associated with checkpoint blockade immunotherapy outcomes, and the demonstration that autoantibodies can mimic inborn errors of immunity – genetic-knockout-like phenotypes only discoverable via antibody profiling.

A two-day event packed with leading speakers, research and cutting-edge presentations on the latest advancements in the discovery & development of cancer immunotherapies with dedicated sessions on different therapeutic modalities, biomarkers, precision and omics-based approaches in IO as well as case studies on innovative preclinical and translational tools.